Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy

Experimental and Therapeutic Medicine

Volumn 4, Issue 1, 2012, Pages 43-48

  Serrano, María José ^a   Rovira, Pedro Sánchez ^b   Martinez Zubiaurre I ^c   Rodriguez, Miguel Delgado ^d   Fernández, Mónica ^b   Lorente, Jose A ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b University Hospital   (Spain)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY OF JAÉN   (Spain)

Author keywords

Circulating tumor cells; Early breast cancer; Neoadjuvant therapy; Overall survival

Indexed keywords

ANTHRACYCLINE; CYTOKERATIN; PACLITAXEL; TAMOXIFEN;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL SELECTION; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; LYMPH NODE;

EID: 84865770110     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.540     Document Type: Article

References (25)

1. Klein CA: The metastasis cascade. Science 321: 1841-1844, 2008.
2. Mego M, Mani SA and Cristofanilli M: Molecular mechanisms of metastasis in breast cancer - clinical applications. Nat Rev Clin Oncol 7: 693-701, 2010.
3. Graves H and Czerniecki BJ: Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Pathol Res Int 2011: 621090, 2011.
4. Pantel K and Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456, 2004.
5. Serrano MJ, Sánchez-Rovira P, Delgado-Rodriguez M and Gaforio JJ: Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer. Cancer Biol Ther 8: 671-675, 2009.
6. Botteri E, Sandri MT, Bagnardi V, Munzone E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A, Curigliano G, et al: Modeling the relationship between circulating tumour cell number and prognosis of metastatic breast cancer. Breast Cancer Res Treat 122: 211-217, 2010.
7. Lin H, Balic M, Zheng S, Datar R and Cote R: Disseminated and circulating tumor cells: role in effective cancer management. Crit Rev Oncol Hematol 77: 1-11, 2011.
8. García-Sáenz JA, Martín M, Maestro ML, Vidaurreta M, Veganzones S, Rafael S, Casado A, Bobokova J, Sastre J, de la Orden V, et al: Circulating tumour cells in locally advanced breast cancer. Clin Transl Oncol 11: 544-547, 2009.
9. Pierga JY, Bidard FC, Mathiot C, Brain E, Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A and Marty M: Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 14: 7004-7010, 2008.
10. Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE and Hoon DSB: Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res 13: 4105-4110, 2007.
11. Wong NS, Kahn HJ, Zhang L, Oldfield S, Yang LY, Marks A and Trudeau ME: Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res Treat 99: 63-69, 2006.
12. Langer R, Ott K, Feith M, Lordick F, Siewert JR and Becker K: Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas. Mod Pathol 22: 1555-1563, 2009.
13. Makhoul I and Kiwan E: Neoadjuvant systemic treatment of breast cancer. J Surg Oncol 103: 348-357, 2011.
14. Pierga JY, Hajage D, Bachelot T, Delaloge S, Brain E, Campone M, Dieras V, Rolland E, Mignot L, Mathiot C and Bidard FC: High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Ann Oncol: 2011. doi:10.1093/annonc/mdr263, 2011.
15. Riethdorf S and Pantel K: Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology 75: 140-148, 2008.
16. Gaforio JJ, Serrano MJ, Sanchez-Rovira P, Sirvent A, Delgado-Rodriguez M, Campos M, de la Torre N, Algarra I, Duenas R and Lozano A: Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer 107: 984-990, 2003.
17. Bidard FC, Mathiot C, Delaloge S, Brain E, Giachetti S, de Cremoux P, Marty M and Pierga JY: Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol 21: 729-733, 2010.
18. Riethdorf S, Müller V, Zhang L, Rau T, Komor M, Roller M, Huober J, Fehm T, Schrader I, Hilfrich J, et al: Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant geparquattro trial. Clin Cancer Res 16: 2634-2645, 2010.
19. Serrano MJ, Lorente JA, Delgado Rodríguez M, Fernández A, Fernández M, de la Torre C, Fernández Izquierdo J and Sánchez Rovira P: Circulating tumour cells in peripheral blood: potential impact on breast cancer outcome. Clin Trans Oncol 13: 204-208, 2011.
20. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791, 2004.
21. Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U, Altendorf-Hofmann A, et al: Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 26: 1208-1215. 2008.
22. Pachmann K, Camara O, Kohlhase A, et al: Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy. J Cancer Res Clin Oncol 137: 821-828, 2011.
23. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, et al: Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10: 8152-8162, 2004.
24. Aguirre-Ghiso JA: Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834-846, 2007.
25. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008.